Literature DB >> 29649489

Albumin levels and cause-specific mortality in community-dwelling older adults.

Chen-Yi Wu1, Hsiao-Yun Hu2, Nicole Huang3, Yi-Chang Chou2, Chung-Pin Li4, Yiing-Jenq Chou5.   

Abstract

To investigate the association between serum albumin levels and cause-specific mortality among community-dwelling older adults. This cohort study was based on data obtained from the government-sponsored Annual Geriatric Health Examination Program for the older adults in Taipei City between 2006 and 2010. The study sample consisted of 77,531 community-dwelling Taipei citizens (≥65 years old). Mortality was determined by matching the participants' medical records with national death files. Serum albumin levels were categorized into <3.6, 3.6-3.7, 3.8-3.9, 4.0-4.1, 4.2-4.3, and ≥4.4 g/dL. Cox proportional hazards regression models were used to evaluate the association between albumin levels and cause-specific mortality. Spline regression was used to calculate the risk of mortality associated with albumin levels, modeled as continuous variables. Community-dwelling older adults had a mean albumin level of 4.3 g/dL, which significantly reduced by age. Compared to albumin levels ≥4.4 g/dL, mildly low albumin levels (4.2-4.3 g/dL) were associated with an increased mortality risk (hazard ratio [HR]: 1.16, 95% confidence interval [CI]: 1.05-1.28 for all-cause mortality), and albumin levels <4.2 g/dL were associated with significantly higher rates of all-cause, cancer, cardiovascular, and respiratory mortalities. In the spline regression, the curve of mortality risk was relatively flat at an albumin level ≥4.4 g/dL, and the mortality risk gradually increased as the albumin level declined. Albumin levels ≥4.4 g/dL were associated with better survival among community-dwelling older adults, and mortality risk increased as the albumin level decreased.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin; Community-dwelling; Mortality; Older adults

Mesh:

Substances:

Year:  2018        PMID: 29649489     DOI: 10.1016/j.ypmed.2018.04.015

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

1.  Development, validation, and visualization of a web-based nomogram to predict 5-year mortality risk in older adults with hypertension.

Authors:  Huanrui Zhang; Wen Tian; Yujiao Sun
Journal:  BMC Geriatr       Date:  2022-05-04       Impact factor: 4.070

2.  Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy.

Authors:  Jong Joo Moon; Yaerim Kim; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Seung Seok Han
Journal:  Kidney Res Clin Pract       Date:  2020-03-31

3.  Plasma lipid concentrations and survival in geriatric population: A retrospective cohort study.

Authors:  Mu-Cyun Wang; Hsiao-Yun Hu; I-Feng Lin; Jhih-Tung Chuang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

4.  Analysis of Quality of Life and Nutritional Status in Elderly Patients with Dysphagia in Order to Prevent Hospital Admissions in a COVID-19 Pandemic.

Authors:  Virginia E Fernández-Ruiz; Rocío Paredes-Ibáñez; David Armero-Barranco; Juan Francisco Sánchez-Romera; Mercedes Ferrer
Journal:  Life (Basel)       Date:  2020-12-31

5.  Impact of the Serum Level of Albumin and Self-Assessed Chewing Ability on Mortality, QOL, and ADLs for Community-Dwelling Older Adults at the Age of 85: A 15 Year Follow up Study.

Authors:  Yoshiaki Nomura; Erika Kakuta; Ayako Okada; Ryoko Otsuka; Mieko Shimada; Yasuko Tomizawa; Chieko Taguchi; Kazumune Arikawa; Hideki Daikoku; Tamotsu Sato; Nobuhiro Hanada
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

6.  Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.

Authors:  Masayuki Kashima
Journal:  Front Nutr       Date:  2021-04-14

7.  Liver Biomarkers Assay in COVID-19 Cases: A Comparison Study between Alive and Dead Patients.

Authors:  Amir Emami; Fatemeh Javanmardi; Ali Akbari; Babak Shirazi Yeganeh; Tahereh Rezaei; Hamid Bakhtiari; Neda Pirbonyeh
Journal:  Iran J Public Health       Date:  2022-01       Impact factor: 1.429

8.  Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease.

Authors:  Shujun Sun; Yiyong Wen; Yandeng Li
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

9.  Body mass index and albumin levels are prognostic factors for long-term survival in elders with limited performance status.

Authors:  Kuan-Yu Lai; Tai-Hsien Wu; Chiu-Shong Liu; Chih-Hsueh Lin; Cheng-Chieh Lin; Ming-May Lai; Wen-Yuan Lin
Journal:  Aging (Albany NY)       Date:  2020-01-16       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.